an upward compatible modality over car-t · [email protected] } +w$5 :b7% tkmm=;9d; x4 , x20 m,...
TRANSCRIPT
![Page 1: An upward compatible modality over CAR-T · info@kohjin-bio.co.jp } +W$5 :b7% TkMm=;9D; x4 , x20 m, x20 m CD56 CD3 day0](https://reader035.vdocuments.us/reader035/viewer/2022070923/5fbb4481796c0c331e0906ec/html5/thumbnails/1.jpg)
Cat. No. 16030400
An upward compatible modality over CAR-T
ü Highly purified and near-fully activated
ü Unique phenotype
ü Simple and highly reproducible
ü Sufficient yield
ü Cost effective
< for RESEARCH USE ONLY >
![Page 2: An upward compatible modality over CAR-T · info@kohjin-bio.co.jp } +W$5 :b7% TkMm=;9D; x4 , x20 m, x20 m CD56 CD3 day0](https://reader035.vdocuments.us/reader035/viewer/2022070923/5fbb4481796c0c331e0906ec/html5/thumbnails/2.jpg)
l ~l 3 3 ( sl E:T=1:1 , 2 s m
NK-resistant Raji
l ce 2 ) - //1 0/ 7ce
:
TEL : [email protected]
:
< for RESEARCH USE ONLY >
x4
,
x20
m ,
x20
m
CD56
CD3
day0 day14
CD3, CD56, CD16 Marker Isotype control
CD16
NK: = 1:137℃ , 2 s
+ 3CD3, CD56, CD16 Isotype control
> : ,
AB 4 12181301 CD3 Dynabeads™ CD3, Invitrogen, 11151D Ficoll-Paque™ OptiPrep™ < PBMC
AdoptCellⓇ-NKNK
Cat. No. 16030400